Personalized Medicine for Pulmonary Hypertension:
نویسندگان
چکیده
Pulmonary hypertension is a convergent phenotype that presents late in the natural history of condition. The current clinical classification patients lacks granularity, and this impacts on development deployment treatment. Deep molecular phenotyping using platform ‘omic’ technologies beginning to reveal genetic architecture underlies phenotype, promising better targeting with new treatments. future treatment pulmonary depends integration information create taxonomy defines patient groups coupled druggable targets.
منابع مشابه
Thalassemia Associated Pulmonary Hypertension
Cardiac disease is the main cause of death in both forms of thalassemia; thalassemia major (TM) and thalassemia intermedia (TI). Pulmonary hypertension (PH) is one of the cardiopulmonary morbidities with high mortality that, if not treated, may trigger right-sided heart failure and premature death. PH is defined as a mean pulmonary artery pressure of ≥25 mmHg at rest or ≥30 mmHg during exercise...
متن کاملPersonalized Medicine for Gliomas
Personalized medicine for cancer entails tailoring therapy for each patient based on unique features of the patient's tumor; physiologic, molecular, genetic and epigenetic. Our ability to molecularly characterize tumor cells has increased dramatically and shown that there are significant differences between samples from patients with the same tumor type. Given this extensive variability in muta...
متن کاملPerspectives of personalized medicine in traditional persian medicine
The approach of personalized medicine has received a great deal of attention over the last century, emphasizing attention to the patient rather than the disease. Personalized medicine tries to plan the patient's condition and treatment method by considering the culture, personal preferences and experiences and health beliefs of the person as well as the values and lifestyle of the person, and e...
متن کاملPersonalized medicine and treatment approaches in hypertension: current perspectives
In the US, hypertension affects one in three adults. Current guideline-based treatment of hypertension involves little diagnostic testing. A more personalized approach to the treatment of hypertension might be of use. Several methods of personalized treatment have been proposed and vetted to varying degrees. The purpose of this narrative review is to discuss the rationale for personalized thera...
متن کاملPersonalized Medicine for Chronic Respiratory Infectious Diseases: Tuberculosis, Nontuberculous Mycobacterial Pulmonary Diseases, and Chronic Pulmonary Aspergillosis.
Chronic respiratory infectious diseases are causing high rates of morbidity and mortality worldwide. Tuberculosis, a major cause of chronic pulmonary infection, is currently responsible for approximately 1.5 million deaths per year. Although important advances in the fight against tuberculosis have been made, the progress towards eradication of this disease is being challenged by the dramatic i...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinics in Chest Medicine
سال: 2021
ISSN: ['1557-8216', '0272-5231']
DOI: https://doi.org/10.1016/j.ccm.2020.10.004